Increasing Access to Antiretroviral Therapy for the Prevention and Treatment of HIV in Infants, Children, and Youth in the United States: Policy Statement.

Abstract

Although significant progress has been made in prevention and treatment of HIV in the United States, nationally and globally, infants and children younger than 13 years have less access to optimal antiretroviral therapy compared with youth (13-24 years) and adults, which can negatively affect health outcomes for those with HIV. Despite youth having nearly as many antiretroviral options for HIV management as adults, optimal HIV management in youth is challenged by psychosocial and structural barriers that result in poor access to HIV prevention and care. Significant barriers remain in providing equitable access to optimal HIV treatment and prevention services in the pediatric population.